Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

But it is an oral version of the GLP-1 analogue that holds the greatest promise for patients with diabetes - and for the company's revenues. Phase 3 trials of injectable semaglutide have shown it ...

Here’s a quick biology lesson on semaglutide’s mechanisms of action (stick with us — we ... the manufacturer of the diabetes and weight loss drugs Mounjaro® and Zepbound®.

The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...

Between May 27, 2021 and April 18, 2023, 800 participants were randomly assigned to receive once-weekly injection of 2.4milligrams of semaglutide or placebo, alongside lifestyle counselling. More than ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

researchers report in a study published in Diabetes Technology & Therapeutics. An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!